| 3 | Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study. (Dhakal B, Zhang MJ, Burns LJ, Tang X, Meyer C, Mau LW, Nooka AK, Stadtmauer E, Micallef IN, McGuirk J, Costa L, Juckett MB, Shah N, Champlin RE, Usmani SZ, Farag SS, Nishihori T, Roy V, Bodiford A, Barnes YJ, Drea EJ, Hari P, Hamadani M) Haematologica 2023 Aug 01;108(8):2249-2254 3 Citations |
| 1 | Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials. (Chhabra S, Callander N, Watts NL, Costa LJ, Thapa B, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Anderson LD Jr, Bal S, Dhakal B, Nathwani N, Shah N, Medvedova E, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Schmidt T, Orlowski RZ, Shain KH, Cowan AJ, Dholaria B, Cornell RF, Jerkins JH, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardson PG, Voorhees PM) Transplant Cell Ther 2023 Mar;29(3):174.e1-174.e10 33 Citations |
| 1 | Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. (Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ) Pediatr Blood Cancer 2022 Oct;69(10):e29812 9 Citations |
| 2 | Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy. (Orfali N, Zhang MJ, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, Munshi PN, Prestidge T, Ringden O, Rizzieri D, Riches ML, Seo S, Solh M, Solomon S, Szwajcer D, Yared J, van Besien K, Eapen M) Transplant Cell Ther 2021 Dec;27(12):993.e1-993.e8 7 Citations |
| 1 | Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations. (Panch SR, Logan B, Sees JA, Bo-Subait S, Savani B, Shah NN, Hsu JW, Switzer G, Lazarus HM, Anderlini P, Hematti P, Confer D, Pulsipher MA, Shaw BE, Stroncek DF) Transplant Cell Ther 2021 Jun;27(6):503.e1-503.e8 1 Citation |
| 1 | The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort Study. (George G, Martin AS, Chhabra S, Eapen M) Biol Blood Marrow Transplant 2020 Dec;26(12):2359-2364 5 Citations |
| 3 | Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield. (Farhadfar N, Hsu JW, Logan BR, Sees JA, Chitphakdithai P, Sugrue MW, Abdel-Azim H, Anderlini PN, Bredeson C, Chhabra S, Diaz MA, Ganguly S, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Lynch DK, Murthy HS, Olsson RF, Papari M, Przepiorka D, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Yared JA, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR) Blood Adv 2020 Feb 25;4(4):706-716 14 Citations |
| 4 | Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors. (Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredeson C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugrue M, Warkentin P, Wingard JR) Biol Blood Marrow Transplant 2020 Jun;26(6):1210-1217 6 Citations |
| 4 | An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis. (Badar T, Dhakal B, Szabo A, Padmanabhan A, Johnson BD, Heidtke S, Esselmann J, Chhabra S, Hamadani M, Hari P, D'Souza A) J Clin Apher 2019 Dec;34(6):686-691 3 Citations |
| 1 | Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. (Waller EK, Logan BR, Fei M, Lee SJ, Confer D, Howard A, Chandrakasan S, Anasetti C, Fernando SM, Giver CR) Blood Adv 2019 Aug 13;3(15):2250-2263 35 Citations |
| 2 | Myeloid malignancies after treatment for solid tumours. (Guru Murthy GS, Abedin S) Best Pract Res Clin Haematol 2019 Mar;32(1):40-46 11 Citations |
| 1 | Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation. (Pahnke S, Egeland T, Halter J, Hägglund H, Shaw BE, Woolfrey AE, Szer J, Working Group Medical of the World Marrow Donor Association) Bone Marrow Transplant 2019 Jun;54(6):858-866 16 Citations |
| 2 | Epigenetic Therapy in a Patient With Down Syndrome and Refractory Acute Myeloid Leukemia. (Becktell K, Houser K, Burke MJ) J Pediatr Hematol Oncol 2019 Jan;41(1):e38-e40 14 Citations |
| 1 | A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation. (Haverkos BM, Huang Y, Elder P, O'Donnell L, Scholl D, Whittaker B, Vasu S, Penza S, Andritsos LA, Devine SM, Jaglowski SM) Bone Marrow Transplant 2017 Apr;52(4):561-566 9 Citations |
| 1 | Collection of hematopoietic CD34 stem cells in rhesus macaques using Spectra Optia. (Haynes LD, Coonen J, Post J, Brunner K, Bloom D, Hematti P, Kaufman DB) J Clin Apher 2017 Oct;32(5):288-294 8 Citations |
| 2 | Modeling Hematopoiesis and Responses to Radiation Countermeasures in a Bone Marrow-on-a-Chip. (Torisawa YS, Mammoto T, Jiang E, Jiang A, Mammoto A, Watters AL, Bahinski A, Ingber DE) Tissue Eng Part C Methods 2016 May;22(5):509-15 57 Citations |
| 1 | Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease. (Vasu S, Geyer S, Bingman A, Auletta JJ, Jaglowski S, Elder P, O'Donnell LC, Bradbury H, Kitzler R, Andritsos L, Blum W, Klisovic R, Penza S, Efebera Y, Hofmeister C, Benson DM, Muthusamy N, Lozanski G, Devine SM) Biol Blood Marrow Transplant 2016 Apr;22(4):658-668 19 Citations |
| 1 | Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use. (Veltri L, Cumpston A, Shillingburg A, Wen S, Luo J, Leadmon S, Watkins K, Craig M, Hamadani M, Kanate AS) Cytotherapy 2015 Dec;17(12):1785-92 29 Citations |
| 1 | Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening. (Lee JB, Billen A, Lown RN, Potter MN, Craddock CF, de Lavallade H, Shaw BE, Sharpe CC) Bone Marrow Transplant 2016 Feb;51(2):286-7 6 Citations |
| 2 | Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia. (Teng RJ, Wu TJ, Sharma R, Garrison RD, Hudak ML) J Formos Med Assoc 2015 Feb;114(2):174-9 1 Citation |
| 6 | Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis. (Dhakal B, D'Souza A, Arce-Lara C, Pasquini M, Saber W, Falvo F, Esselman J, Zellner K, Fenske T, Hari PN, Hamadani M) Bone Marrow Transplant 2015 Apr;50(4):610-2 6 Citations |
| 1 | A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies. (Shaw BE, Confer DL, Hwang W, Pulsipher MA) Bone Marrow Transplant 2015 Mar;50(3):334-40 50 Citations |
| 3 | Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. (Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2015 Jan;21(1):165-71 28 Citations |
| 1 | Drug-induced immune neutropenia/agranulocytosis. (Curtis BR) Immunohematology 2014;30(2):95-101 83 Citations |
| 8 | Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis. (Dhakal B, Strouse C, D'Souza A, Arce-Lara C, Esselman J, Eastwood D, Pasquini M, Saber W, Drobyski W, Rizzo JD, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2014 Dec;20(12):1926-31 24 Citations |
| 1 | Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies. (Feliu J, Clay J, Raj K, Barber L, Devlia V, Shaw B, Pagliuca A, Mufti G) Br J Haematol 2014 Nov;167(3):426-8 5 Citations |
| 2 | Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. (Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL) Blood 2014 Jun 05;123(23):3655-63 102 Citations |
| 2 | Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF. (Chaudhary L, Awan F, Cumpston A, Leadmon S, Watkins K, Tse W, Craig M, Hamadani M) J Clin Apher 2013 Oct;28(5):359-67 28 Citations |
| 1 | Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies. (Awan F, Kochuparambil ST, Falconer DE, Cumpston A, Leadmon S, Watkins K, Deremer D, Jillella A, Craig M, Hamadani M) Bone Marrow Transplant 2013 Oct;48(10):1279-84 46 Citations |
| 3 | Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL) Blood 2013 Jan 03;121(1):197-206 107 Citations |
| 1 | Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies. (Hamadani M, Kochuparambil ST, Osman S, Cumpston A, Leadmon S, Bunner P, Watkins K, Morrison D, Speir E, Deremer D, Kota V, Jillella A, Craig M, Awan F) Biol Blood Marrow Transplant 2012 Jul;18(7):1128-35 61 Citations |
| 2 | Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. (Keever-Taylor CA, Devine SM, Soiffer RJ, Mendizabal A, Carter S, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Goldstein SC, Stadtmauer EA, O'Reilly RJ) Biol Blood Marrow Transplant 2012 May;18(5):690-7 55 Citations |
| 1 | VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study. (Chang JE, Peterson C, Choi S, Eickhoff JC, Kim K, Yang DT, Gilbert LA, Rogers ES, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS) Br J Haematol 2011 Oct;155(2):190-7 51 Citations |
| 1 | Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. (Shaw BE, Confer DL, Hwang WY, Pamphilon DH, Pulsipher MA) Haematologica 2011 Jul;96(7):942-7 68 Citations |
| 2 | Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. (Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M) Biol Blood Marrow Transplant 2011 Jul;17(7):1018-24 55 Citations |
| 1 | Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. (Duarte RF, Shaw BE, Marín P, Kottaridis P, Ortiz M, Morante C, Delgado J, Gayoso J, Goterriz R, Martínez-Chamorro C, Mateos-Mazón JJ, Ramírez C, de la Rubia J, Achtereekte H, Gandhi PJ, Douglas KW, Russell NH) Bone Marrow Transplant 2011 Jan;46(1):52-8 111 Citations |
| 3 | Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL) Blood 2009 Apr 09;113(15):3604-11 220 Citations |
| 1 | Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. (Tulpule S, Shaw BE, Makoni P, Little AM, Madrigal JA, Goldman JM) Bone Marrow Transplant 2009 Jul;44(2):129-30 22 Citations |
| 1 | Granulocyte colony-stimulating factor administration: adverse events. (D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P) Transfus Med Rev 2008 Oct;22(4):280-90 94 Citations |
| 1 | Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. (McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D, Eapen M, Hirsch B, Kuter D, Lazarus E, Pamphilon D, Stroncek D, Sugarman J, Wilson R) Transfusion 2008 Sep;48(9):2008-25 24 Citations |
| 1 | Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products. (Gordon MK, Sher D, Karrison T, Kebriaei P, Chuang K, Zhang Y, McDonnell D, Artz A, Godley L, Odenike O, Rich E, Michaelis L, Thirman MJ, Wickrema A, van Besien K, Larson RA, Stock W) Leuk Lymphoma 2008 Mar;49(3):531-7 8 Citations |
| 1 | Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. (Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ) Pediatr Blood Cancer 2008 Mar;50(3):667-70 22 Citations |
| 1 | AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. (Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P) Blood 2006 May 01;107(9):3772-8 175 Citations |
| 1 | Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. (Khoury HJ, Loberiza FR Jr, Ringdén O, Barrett AJ, Bolwell BJ, Cahn JY, Champlin RE, Gale RP, Hale GA, Urbano-Ispizua A, Martino R, McCarthy PL, Tiberghien P, Verdonck LF, Horowitz MM) Blood 2006 Feb 15;107(4):1712-6 77 Citations |
| 1 | Neonatal alloimmune neutropenia attributed to maternal immunoglobulin G antibodies against the neutrophil alloantigen HNA-1c (SH): a report of five cases. (Curtis BR, Reno C, Aster RH) Transfusion 2005 Aug;45(8):1308-13 47 Citations |
| 1 | Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization. (Dincer AP, Gottschall J, Margolis DA) J Pediatr Hematol Oncol 2004 Nov;26(11):761-3 37 Citations |
| 1 | Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates. (Hematti P, Tuchman S, Larochelle A, Metzger ME, Donahue RE, Tisdale JF) Stem Cells 2004;22(6):1062-9 18 Citations |
| 1 | Neonatal neutropenia and bacterial sepsis associated with placental transfer of maternal neutrophil-specific autoantibodies. (Davoren A, Saving K, McFarland JG, Aster RH, Curtis BR) Transfusion 2004 Jul;44(7):1041-6 30 Citations |
| 1 | Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates. (Kuramoto K, Follmann DA, Hematti P, Sellers S, Agricola BA, Metzger ME, Donahue RE, von Kalle C, Dunbar CE) Blood 2004 Jun 01;103(11):4070-7 14 Citations |
| 1 | Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates. (Hematti P, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE) Blood 2003 Mar 15;101(6):2199-205 46 Citations |
| 1 | Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation. (Hematti P, Sloand EM, Carvallo CA, Albert MR, Yee CL, Fuehrer MM, Blancato JK, Kearns WG, Barrett JA, Childs RW, Vogel JC, Dunbar CE) Exp Hematol 2002 Aug;30(8):943-9 41 Citations |
| 2 | Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. (Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins RH Jr) J Clin Oncol 2002 Jan 15;20(2):405-12 248 Citations |
| 1 | Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. (Goorin AM, Harris MB, Bernstein M, Ferguson W, Devidas M, Siegal GP, Gebhardt MC, Schwartz CL, Link M, Grier HE) J Clin Oncol 2002 Jan 15;20(2):426-33 198 Citations |
| 1 | Pilot study of low-dose interleukin-11 in patients with bone marrow failure. (Kurzrock R, Cortes J, Thomas DA, Jeha S, Pilat S, Talpaz M) J Clin Oncol 2001 Nov 01;19(21):4165-72 61 Citations |
| 1 | Granulocyte colony-stimulating factor in the cord blood of premature neonates born to mothers with pregnancy-induced hypertension. (Tsao PN, Teng RJ, Tang JR, Yau KI) J Pediatr 1999 Jul;135(1):56-9 30 Citations |
| 1 | Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. (Leung W, Chen AR, Klann RC, Moss TJ, Davis JM, Noga SJ, Cohen KJ, Friedman AD, Small D, Schwartz CL, Borowitz MJ, Wharam MD, Paidas CN, Long CA, Karandish S, McMannis JD, Kastan MB, Civin CI) Bone Marrow Transplant 1998 Nov;22(10):971-9 63 Citations |
| 1 | Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation. (Ferrajoli A, Talpaz M, Kurzrock R, Harris D, Van Q, Estey EH, Estrov Z) Leuk Lymphoma 1998 Jul;30(3-4):279-92 8 Citations |
| 1 | Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia. (Estrov Z, Talpaz M, Ku S, Harris D, Van Q, Beran M, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R) Leuk Res 1998 Apr;22(4):341-53 32 Citations |
| 1 | Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences. (Gisslinger H, Kurzrock R, Wetzler M, Tucker S, Kantarjian H, Robertson B, Talpaz M) Leuk Lymphoma 1997 Mar;25(1-2):121-33 19 Citations |
| 1 | Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. (Estrov Z, Talpaz M, Ku S, Harris D, LaPushin R, Koller CA, Hirsh-Ginsberg C, Huh Y, Yee G, Kurzrock R) Leukemia 1996 Sep;10(9):1534-43 17 Citations |
| 1 | Inhibition of mouse placental lactogen-II release from placental cells by interleukin-1 after mid-pregnancy. (Yamaguchi M, Sakata M, Ogura K, Adachi K, Mammoto A, Miyake A) J Endocrinol 1995 Dec;147(3):423-9 3 Citations |
| 1 | Adjuncts to antibacterial therapy. (Frank MO, Mandell GL) Infect Dis Clin North Am 1995 Sep;9(3):769-81 6 Citations |
| 1 | Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. (Estrov Z, Talpaz M, Mavligit G, Pazdur R, Harris D, Greenberg SM, Kurzrock R) Am J Med 1995 Jun;98(6):551-8 67 Citations |
| 1 | Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma. (Wetzler M, Estrov Z, Talpaz M, Markowitz A, Gutterman JU, Kurzrock R) J Intern Med 1993 Oct;234(4):417-20 44 Citations |
| 1 | Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. (Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Gutterman JU, Talpaz M) Blood 1992 Apr 15;79(8):1938-45 82 Citations |
| 1 | The pathogenesis of Sweet's syndrome. (Cohen PR, Kurzrock R) J Am Acad Dermatol 1991 Oct;25(4):734 36 Citations |
| 1 | Hairy cell leukaemia: review of treatment. (Kurzrock R, Talpaz M, Gutterman JU) Br J Haematol 1991 Oct;79 Suppl 1:17-20 25 Citations |
| 1 | Biological molecules in the treatment of hematological disorders. (Kurzrock R, Talpaz M, Gutterman U) Sangre (Barc) 1989 Feb;34(1):53-8 |
